06 July 2021 : Original article
Liver Transplantation: A 10-Year Low-Volume Transplant Center Experience in Kazakhstan
Jamilya Saparbay1ABCDEF*, Janat Spatayev1ADEF, Abylaikhan Sharmenov1AB, Shokan Aytbayev1BCD, Aizhan Uristenova1B, Adilbek Mukazhanov1BCDE, Asan Zhexembayev1ADEDOI: 10.12659/AOT.931786
Ann Transplant 2021; 26:e931786
Table 1 Demographics and clinical characteristics of liver recipients.
| Variable | Mean (SD) | Median (range) | N (%) |
|---|---|---|---|
| Age | 44 (11) | 46.5 (15–63) | 64 |
| Gender (Male/Female) | 30 (47)–34 (53) | ||
| Cause of ESLD | |||
| PBC | 9 (14) | ||
| HCV | 4 (6.35) | ||
| HBV | 9 (14) | ||
| AIH | 7 (10.9) | ||
| HCC | 2 (3.17) | ||
| HBV+HDV | 21 (32.8) | ||
| HBV+HDV+HCV | 1 (1.6) | ||
| Cryptogenic cirrhosis | 4 (6.3) | ||
| NASH | 3 (4.7) | ||
| Others | 4 (6.3) | ||
| MELD (points) | 16 (6) | 15 (6–34) | 64 |
| Child-Pugh classification | |||
| A | 5 | ||
| B | 31 | ||
| C | 28 | ||
| Bilirubin (μmol/l) | 135.01 (141.6) | 136.8 (14.4–434) | 64 |
| Creatinine (μmol/l) | 62.69 (22.8) | 63.4 (30–143.75) | 64 |
| BMI – body mass index; ESLD – end-stage liver disease; PBC – primary biliary cirrhosis; HCV – hepatitis C virus; HBV – hepatitis B virus; AIH – autoimmune hepatitis; HCC – hepatocellular carcinoma; NASH – non-alcoholic steatohepatitis; MELD – model of end-stage liver disease. | |||